
|Videos|February 9, 2022
INSPIRE and IMvigor011 Trials
Jason Starr, DO, discusses the INSPIRE and IMvigor011 studies that focused on the use of ctDNA in MRD.
Advertisement
Episodes in this series
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
2
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
3
New TROP2-Targeted ADC Shows Promise in TNBC: Erika Hamilton, MD
4
As Milestone Nears, an Early Investigator Reflects on Lessons of Imatinib
5














































